Company profiles


Abbott Laboratories Trading (Shanghai) Co., Ltd.
31/F Ciro’s Plaza,288 West Nan Jing Road, Shanghai 200003, P.R. China
Tel:+86 21 23204185
At Abbott, we’re all about helping you live the best life you can through good health. We keep your heart healthy, nourish your body at every stage of life, help you feel and move better, and bring you information, medicines and breakthroughs to manage your health. Every day and around the world, we’re discovering new ways to make life better.

Global Medicines Development
1 MedImmune Way, Gaithersburg,
AstraZeneca is pushing the boundaries of science to create life-changing medicines that aim to reduce the global burden and complications of diabetes. Driven to redefine outcomes for diabetes patients, our current portfolio consists of the three newest classes of non-insulin, antidiabetic treatments that support individualised treatment approaches: SGLT-2 inhibitors, GLP-1 receptor agonists and DPP-4 inhibitors. Our commitment to diabetes is exemplified by the depth and breadth of our global clinical research programme. This commitment is advancing understanding of the treatment effects of our diabetes medicines in broad patient populations, as well as exploring combination treatment approaches resulting in more patients achieving treatment success earlier in their disease progression. Our ambition is to reduce the longterm impact of diabetes. As a core strategic area for the company, we are
focusing our research and development efforts in diverse populations
and patients with significant co-morbidities, such as cardiovascular
disease, heart failure, obesity, non-alcoholic steatohepatitis (NASH), and chronic kidney disease.

Bayer (China) Limited
Telephone: +86 10 65893000
Fax: +86 10 65893243
Bayer Health care
Tel: +86 10 5921 8282
Fax: +86 10 5921 8181
Bayer (China) Limited
No 33, Huayuan Shiqiao Road, Pudong 18-19/F, 23-26/F, Citigroup Tower, Shanghai 200120, China

Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time.
A growing and aging world population requires an adequate supply of food and improved medical care. Our research and development activities are therefore focused on improving people’s quality of life by preventing, alleviating and treating diseases. At the same time, we are making an important contribution to providing a reliable supply of high-quality food, feed and plant-based raw materials. Our understanding of the biochemical processes in living organisms helps us address these demanding challenges.
We are committed to operating sustainably and addressing our social and ethical responsibilities. We also respect the interests of all our stakeholders. Employees with a passion for innovation enjoy excellent development opportunities at Bayer.


   In January 2011, Boehringer Ingelheim and Eli Lilly and Company announced an alliance in diabetes that centres on compounds representing several of the largest diabetes treatment classes. The alliance leverages the strengths of two of the world’s leading pharmaceutical companies. By joining forces, the companies demonstrate commitment in the care of people with diabetes and stand together to focus on patient needs. Depending on geographies, the companies either co-promote or separately promote the respective molecules each contributed to the alliance.


Shenyang Sunshine Pharmaceuticals CO., Ltd
Headquarters 1st 3, 10th Road, Economic and Technological Development Zone
Shenyang, China 110027
Tel: +86 24 2538 6000
Fax: +86 24 2581 1821

3S Pharmaceutical Group is a leading bio-pharmaceutical company integrating R&D, production and sales, with a focus on improving the life quality of patients with high-quality medicines to benefit human health. At present, the Group owns more than 70 national invention patents and has launched more than 30 kinds of products into the market, covering several treatment fields, among others, cancer, autoimmune, kidney disease, metabolism and dermatology. The Group owns 4 R&D centers of the National Engineering Research Center of Antibody Medicine and dual platforms for biopharmaceutical and chemical medicine. There are 32kinds of products under R&D, 22 kinds of them are under R&D as the national first-class new drugs. The Group also owns 5 production bases complying with GMP standards. In the future, 3S Pharmaceutical Group will continue to uphold the concept of “Care for Life, Cherish Life, Create Life” to create a world's leading bio-pharmaceutical company in China.

CR Double Crane
Suite 315, No.12 Ziming Mansion, Xinzhong street, Dongcheng District, Beijing, China, 100027
CR Double-Crane Pharmaceuticals Co., Ltd (hereinafter referred to as CR Double-Crane) is a pharmaceuticals company with 80 years of brilliant history. Formerly known as Beijing Pharmaceuticals Factory, the company was listed on Shanghai Stock Exchange in 1997 with Stock Code as 600062. In 2010, it was merged into China Resources (Group) Co, Ltd. which is one of the Global 500 companies and became the main manufacturer of chemical medicines under the Group. In 2012, the company was officially renamed from Beijing Double-Crane Pharmaceuticals Co., Ltd. to CR Double-Crane Pharmaceuticals Co., Ltd.
Sticking to the company mission of “caring for people and their health”, CR Double-Crane is always making great effort and keeping its faith. Today, the company has become a large-size listed pharmaceuticals group company with over ten subsidiaries and more than 12,000 staff. It focuses on sectors such as infusion, cardiovascular and cerebrovascular, endocrine, and pediatric medicines and has many famous products such as Compound Reserpine and Triamterene Tablets (No.O), Gliquidone Tablets , Hydroxyethyl Starch(200/0.5)and Sodium Chloride Injection (Ying Yuan).
Levofloxacin Mesylate (LVFX), Piperacillin Sodium and Sulbactum Sodium (PIP/SBT) for Injection (4:1) (Yi Jun), Pitavastatin Calcium Tablets (Guan Shuang), Calf Pulmonary Surfactant for Injection (Calsurf), and Pediatric Compound Amino Acid Injection.
As one of the first pharmaceuticals companies as well as the first state-owned company in China which acquired GMP certification, CR Double-Crane has established a scientifically strict quality assurance system, committing to provide medicines with significant curative effect to the society. In 2014, the company continued to improve its social responsibility management system and established an all-around social responsibility structure management system. It has been awarded as the “Five-star Corporation in the Fulfillment of Social Responsibilities in Chinese Industry”, one of the “100 Pharmaceuticals Companies”, and one of the “G20 Excellent Companies”. It has won the award of “Excellent Quality” in the 10th Safe Medicine for the People Campaign with its No.O, Gliguidone and BFS.
In 2014, with “strategically guided, structure improvement, and reform and development” as its theme, and focusing on deepening of strategy, lean management, internal and external synergy, all staff performance, and team building, the company carried out all works smoothly. In this year, the company has reported a revenue of RMB4.23 billion in its main business and a net profit of RMB540 million. In 2015, China Resources Group proposed “5M” requirements on the management of its subsidiaries. Therefore, the company will start with these “5M”requirements and continue to expand, aiming to be the leader in Chinese pharmaceutical industry and making CR Double-Crane a strong and big brand for a long time.

Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is a large-scale pharmaceutical company that produces Chinese and Western medicines and biological drugs.
Dongbao has been actively engaged in the production of Biopharmaceuticals, especially the reassembly of human insulin, and is one of the pioneer manufacturers.
In Dongbao, innovative R&D projects, advanced technology facilities, strict quality control systems, effective marketing strategies, and satisfactory after-sales service are integrated into a well-organized business management system.
Since its establishment, Tonghua Dongbao has been committed to improving people's lives and increasing social values. Due to its achievements, Dongbao is being widely recognized by the international community and will strive to promote its international cooperation.

East China
No.866,Moganshan Road,Hangzhou
Tel: 0571-89903388
Fax: 0571-89903366

HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL locates near the beautiful West Lake. The company was founded in 1992, December 31. It is a comprehensive pharmaceutical enterprise that focus on medicine, western medicine, biological technology product and its preparations.

Gowell Pharmaceuticals was founded in 2005, and the headquarters is located in the High-tech Industrial Development Zone of Chengdu, Sichuan. Our company's important product is omega-3 fatty acids, and we have developed several generic and innovative drugs for this product. In the next five years, we will have 3 to 5 competitive new products listed each year. Omega-3 Treasure is an epoch-making Omega-3 product which is the only prescription fish oil on the domestic market. As a high-tech pharmaceutical company integrating R&D, production and marketing, we are committed to technological innovation, high-standard quality control and professional marketing, creating value for customers, creating a stage for realizing employees' vision, and producing high-quality products and services. We have always been contributing to society and fulfilling our corporate responsibilities.


Jiangsu Hansoh Pharmaceutical Group Co., Ltd. was established in July, 1995. It has developed into a new pharmaceutical group featuring R&D, manufacture, sales and pharmaceutical investment of drugs. There are more than 40 products launched into the market which cover six therapeutic categories: oncology, antibiotics, psychotropic, antidiabetics, gastro-intestinal and cardiovascular area. Since its inception, Hansoh has evolved into a flagship enterprise for R&D and production in China, a Top 30 enterprise of China's Pharmaceutical Industry, and one of the most innovative pharmaceutical enterprises in China. 
Adhering to the concept of management innovation, technology innovation and product innovation, Hansoh will accelerate collection and fusion of development factors including top-level talents, innovative technology and lean manufacturing, along with peers in the international pharmaceutical field, hand in hand and shoulder by shoulder, to jointly endeavor bravely to contribute wisdom and strength to health of mankind. 
We are looking forward to promoting great cooperative relationships with customers from all over the world.  


Johnson&Johnson Medical(Shanghai) Ltd.
Building A,Xin Yan Mansion,65 Gui Qing Road,
Xuhui,Shanghai 200233,China
T:8621 3337 8020

With a vision to create a world without limits for people with diabetes, LifeScan, Inc. is a world leader in blood glucose monitoring – globally more than 20 million people depend on the company’s OneTouch® brand products to help them manage their diabetes. The LifeScan portfolio includes personal blood glucose meters, testing strips, lancets, point of care testing systems and integrated digital solutions.
For over 35 years, LifeScan has had an unwavering commitment to improving the quality of life for people with diabetes. Through robust history of research, technological advancements and successful product launches, LifeScan has developed products defined by simplicity, accuracy and trust. Recent innovations such as the new OneTouch VerioVuesystem and the OneTouch Verio Flex® meter。
LifeScan is headquartered in Chesterbrook, Pennsylvania and Zug, Switzerland, and has a 340,000 square foot state-of-the-art manufacturing and distribution facility in Inverness, Scotland. With more than 2,000 employees LifeScan serves more than 90 countries. For more information, visit and

Medtronic plc
Floor 6-17, Building B, The New Bund World
Trade Center Phase I , No. 5, Lane 255, Dong Yu Road, Pudong, Shanghai 200126, P.R.China
Tel: +86-21 2032 5986

Medtronic plc (, headquartered in Dublin, Ireland, is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 86,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take health care Further, Together.

Merck Serono Co.,Ltd
25F,NUO Center office,No.A2,jiangtai Road, Chaoyang District, Beijing

With over2000 employees and business presence throughout the country, Merck Healthcare is committed to serving China and markets17medicines in7 major therapeutic areas. Merck Healthcare China has deep expertise in fertility and thyroid therapeutic areas, and has strong presence in CV, endocrinology and oncology. The R&D Beijing Hub, established in November 2009, is an integrated R&D facility, aimed at stimulating innovation, introducing new medicines to China even Asia paralleling market timelines in the West, and leading research and development into new treatment solutions for critical diseases in Asia.
Merck’s main therapeutic areas include fertility, oncology, cardiovascular, surgery and emergency, thyroid disease, diabetes, allergy. Product brands include Gonal-f® to treat infertility, the assistive reproduction products Ovidrel® , Luveris® , Cetrotide® , and Crinone®,as well as IVF lab digital tracking deviceGidgetTM; oncology product Erbitux®for the treatment of RAS WT Mcrc and Xalkori® to treat non-small cell lung cancer (NSCLC) underco-promotion with Pfizer;Concor®for high blood pressure, Stilamin® for acute gastrointestinal diseases; Euthyrox® for hypothyroidism and Thyrozol® for hyperthyroidism; Glucophage®, Glucophage XR®and Invokana®for T2DM withexclusively promotion rightand Doxium®for diabetic ophthalmic complication, and NHD for allergies.

Shanghai MicroPort Lifesciences Co.,  Ltd
Building#24,588 Tianxiong Rd.SIMZ Bio Business Park Shanghai 201318, P.R.China
Tel: 021-38954600-3750
Shanghai MicroPort Lifesciences Co., Ltd. was founded in the Shanghai International Medical Zone on April 28, 2008. It is a wholly owned subsidiary of Shanghai MicroPort Medical (Group) Co., Ltd. and its primary focus is on the development, manufacture, monitoring and management of medical devices for the treatment of diabetes and disorders of sexual development.


For 125 years, MSD has been a global health care leader working to help the world be well. MSD is a tradename of Merck & Co., Inc., with headquarters in Kenilworth, N.J., USA. Through our prescription medicines, vaccines, biologic therapies, and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. For more information, visit or
About MSD in China
China is one of the most critical markets for MSD’s growth strategy. MSD China is powered by three engines: commercial operation headquartered in Shanghai, research and development in Beijing, and manufacturing in Hangzhou. We are committed to bringing quality innovative medicines, vaccines, and services to more Chinese people. For more information, visit, or follow us on WeChat at msd_china

Novartis Pharmaceuticals (China)
2F, Building 1,
No. 4218 Jingke RoadZhangjiang Hi-Tech Park, PudongShanghai, 201203, China
Tel: 021-61606000
Fax: 02161603162
Novartis are inspired by patients every day.
This inspiration motivates us to revolutionize the research, development and manufacturing of quality innovative medicines that help people live longer with a better quality of life giving them more time to do the things that matter to them.
To do our best for patients we do not accept the status quo. We work to enable patient access worldwide so that patients and society can benefit as quickly as possible.
The depth and strength of our pipeline enables us to change the practice of medicine, and to bring more breakthroughswith real benefits to patients and society.   
We partner with people and organizations around the world because by working together we can make a greater difference.
We continually challenge ourselves to the highest standards of compliance, integrity and performance in all that we do to ensure a sustainable future of innovation for patients, society and Novartis.

Novo Nordisk (China) Pharmaceuticals Co., Ltd.
18F, East Tower, World Financial Center
No.1 East 3rd Ring Middle Road, Chaoyang District 100020 Beijing China
Tel: +86 10 5961 5858
Fax: +86 10 6505 6668

Novartis are inspired by patients every day.
This inspiration motivates us to revolutionize the research, development and manufacturing of quality innovative medicines that help people live longer with a better quality of life giving them more time to do the things that matter to them.
To do our best for patients we do not accept the status quo. We work to enable patient access worldwide so that patients and society can benefit as quickly as possible.
The depth and strength of our pipeline enables us to change the practice of medicine, and to bring more breakthroughswith real benefits to patients and society.   
We partner with people and organizations around the world because by working together we can make a greater difference.
We continually challenge ourselves to the highest standards of compliance, integrity and performance in all that we do to ensure a sustainable future of innovation for patients, society and Novartis.

Omron Medical (Beijing) Co., Ltd. is a subsidiary of Omron Health Medical (China) Co., Ltd. which is mainly responsible for the sales and after-sales service of Omron medical products and other internationally renowned medical equipment on the Chinese Market.
Omron Medical continuously concentrates on cutting-edge technology and devotes ourselves to improving people's lives and medical effect through valuable innovation, from disease prevention, diagnosis, treatment to family care and healthy lifestyle.With many years of advanced technology, rich clinical experience and profound consumer insight, Omron Medical is creating integrated innovative solutions in healthcare that deliver better care to more people. Our Mission: Focus on early detection and promotion of electronization in hospital.The main product line covers the fields of blood vessel and metabolism, respiratory, health examination, newborn, environmental management and other cutting-edge technologies and products. It is committed to providing high-quality health solutions and building a sound health service system
Omron Medical is headquartered in Beijing and has branches in Shanghai, Guangzhou, Xi'an and Chengdu. Products and services cover the whole country and have won praise from well-known experts, clinicians and patients. Omron Medical has become one of the most competitive brands in the market. With professional technology and first-class service, many of its products have the privilege of being listed in the MMC hardware equipment standards, providing professional inspection data for MMC.

38/F, CITIC square, 1168 Nanjing Road(W) Shanghai 200041
Tel: (021) 60432500
Fax: (021) 52925885
Roche Diagnostics (Shanghai) Limited Contact Address:8/F,Building2,The Hub No.900.Shen Chang Road, Shanghai, 200335 P.R. China

Roche was founded on October 1st, 1896. The founder, Fritz Hoffmann-La Roche, was among the first to recognize that the industrial manufacture of standardized medicines would be a major advance in the fight against disease. 
Today, Roche employs more than 85,000 people and sells its products in more than 150 countries. Roche ranks among the world’s leading healthcare companies and has two strong core businesses: diagnostics and pharmaceuticals. With our combined strength in pharmaceuticals and diagnostics, we are better equipped than any other company to further drive personalized healthcare. We believe it’s urgent to deliver medical solutions right now – even as we develop innovations for the future. We are passionate about transforming patients’ lives. We commit ourselves to scientific rigor, unassailable ethics, and access to medical innovations for all. We do this today to build a better tomorrow.

Sanofi (China)
19F Tower III, Kerry Center 1228
Middle Yan’an Road, Jing An District,
Shanghai 200040
Tel: +86 021 2226 6666

Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare. More than 110,000 people at Sanofi are dedicated to make a difference on patients’ daily life, wherever they live and enable them to enjoy a healthier life.

905. Route De Saran, 45529 Gidy, France
Tel: 33 1 55 72 75 73
Fax: 33 1 55 72 57 65
Servier is an international pharmaceutical group, governed by a non-profit foundation.It is the 2nd french pharmaceutical company with 3 Research Centers, 16 Production Sites, 15 International Centers of Therapeutic Research. Servier China is an industry leader in the fields of cardiovascular and metabolism, and will actively expand its business in oncology


SPH Sine pharmaceutical Laboratories Co. Ltd.
No. 905, new Jinqiao Road, Pudong, Shanghai
Tel: 021-58995818 

Sine was founded in 1916 in Shanghai, and now is a wholly-owned
holding company by Shanghai Pharmaceuticals Holding Co., Ltd (“SPH”), which is one of biggest pharmaceutical groups in China.
Sine is the biggest industrial subsidiary of SPH. Sine is an R&D, manufacture distribution and retail integrated company .
Sine owns 9 industrial manufacture(2 of them are JVs), 3 commercial sales companies, 1 purchasing company, 1 independent R&D Center and 2 hosting companies.
SINE owns 1063 product approvals in over 20 dosage forms and 14 treatment areas。
 Four Focused Therapeutic Areas:Digestive system Drug,Metabolic System Drugs, Cardiovascular System Drugs, Eye System Drugs.3 first class new drugs, 17 patented products,17 the first imitation products,  55 products own leading market share.
   4products have sales revenue exceeding RMB 100 million, 6 products have sales revenue exceeding RMB 50 million 

Terumo Medical(Shanghai) Co.,LTD
Zip:200052 Rm,901-903, City Point, No.666 West Huaihai Road, Shanghai, China
Tel : 021-62371155

Terumo was founded in 1921 to support fundamental public health by achieving the manufacture of quality thermometers in Japan. With our corporate mission of “Contributing to Society through Healthcare,” we have advanced since then along with healthcare to now do business in over 160 countries throughout the world.
In addition to providing a stable supply of the highest-quality products and services to patients and medical settings, we have strived to offer solutions for the multitude of issues facing medicine, through efforts including reducing the burden on patients, improving healthcare safety, preventing infections, and seeking greater medical cost efficiency.
Healthcare needs are diversifying in response to changes that include population aging in developed nations, contrasted by rapid economic growth in emerging nations.
Further, the evolution of scientific technology, including artificial intelligence, digitalization, robotics, and regenerative medicine, is revolutionizing both healthcare and the industry that supports it.
To continue our contribution to ever-changing medical settings globally, we will utilize the overall strengths of the Terumo Group toward creating new value for healthcare. In addition to product quality, we will also strive to provide "Total Quality," which includes the quality of supply and services as well.
As a global corporation with unique excellence, Terumo Group will achieve world-class quality to bring innovations of value to patients awaiting better healthcare throughout the world.

Beijing Tide Pharmaceutical Co., Ltd
Mailing address:No.8 East Rongjing Street,
              Beijing Econnomic-technological
              Development Area(BDA),
              Beijing, P.R.China
Beijing Tide Pharmaceutical Co., Ltd is a Sino-foreign joint venture that established in May 1995 and located at the core of Beijing Economic-Technological Development Area (DBA). Tide is the first high-tech pharmaceutical enterprise in China with the capability of developing, manufacturing as well as marketing series of targeted drugs.

Through adhering to the principle of “Care for Life and Keep Innovating” and taking independent innovation, independent development as well as introducing, absorbing and re-innovating as development direction, Tide strives to develop new drugs with proprietary intellectual property rights. Based on keeping a foothold inland and opening eyes to the whole world, it will make unremitting endeavor to provide novel drug products with higher quality and improve public health level.

Yiling Pharmaceutical
Add: No.238 Tianshan Street,High-Tech Zone,Shijiazhuang  Tel: 4007898989
Over the years, Yiling Pharmaceutical’s unwavering commitment to developing new herbal medicinal products using Collateral Disease Theory in TCM has led to more than 10 patent drugs with market exclusivity, 200 worldwide patents, 30 key research project funds (e.g., Project 973, Project 863) supported by MOH, MOST, SATCM and Chinese NSF, in addition to many other national and international medical science and technology awards. Yiling Pharmaceutical has built multiple state-of-the-art manufacturing facilities capable of producing high quality drug products in various formulations under cGMP. The chemical and herbal drugs have been exported to many countries, including USA, UK, Canada, Russia, Korea, Vietnam, etc.

Ningbo  Zeshi Medical Science Co., Ltd.
Room 1886  No. 1558 Jiangnan Road, Ningbo High-Tech zone
Tel: 0574-88566200
Zeshi medical is a team focus on the promotion of innovative medical devices and technologies; provide valuable new methods for clinic. We are the Chinese partner of Israeli VIVI cooling products.
VIVI cooling products is built for patients by experts in cooling technologies to address your needs. No battery to charge, no water or ice to immerse in, no pre-cooling in refrigerator. It’s based on a combination of unique insulation material, heat absorbing chemical together with monitoring and control electronics. The proprietary technology used with VIVI cooling products combines the three to tailor a user friendly compact solution.